Dizal Pharmaceuticals
Clinical trials sponsored by Dizal Pharmaceuticals, explained in plain language.
-
New hope for Hard-to-Treat lymphoma: experimental drug DZD8586 enters phase 2 trial
Disease control CompletedThis phase 2 trial tests an experimental drug called DZD8586 in 59 adults with diffuse large B-cell lymphoma that has come back or not responded to previous treatment. The study aims to see if the drug can shrink tumors and to understand its side effects and how the body processe…
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New pill targets Hard-to-Treat lymphoma in early human test
Disease control CompletedThis early-stage trial tests an experimental oral drug called DZD8586 in adults with B-cell Non-Hodgkin lymphoma that has returned or stopped responding to standard treatments. The study aims to find a safe dose and check whether the drug can shrink tumors. Participants take the …
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill shows promise for Tough-to-Treat lymphoma
Disease control CompletedThis phase 2 trial tested an oral drug called AZD4205 in 57 adults with relapsed or refractory peripheral T-cell lymphoma, a rare blood cancer. The study aimed to see if the drug can shrink tumors and how safe it is. Participants took a capsule once daily in 28-day cycles.
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Healthy men swallow radioactive drug to track its path
Knowledge-focused CompletedThis study gave 6 healthy men a single dose of a radioactive form of the experimental drug DZD8586. The goal was to see how the drug moves through the body, how it is broken down, and how it leaves the body in urine and stool. This information helps researchers understand the dru…
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC